Truist Financial Corp Zai Lab LTD Transaction History
Truist Financial Corp
- $61.3 Billion
- Q1 2025
A detailed history of Truist Financial Corp transactions in Zai Lab LTD stock. As of the latest transaction made, Truist Financial Corp holds 6,607 shares of ZLAB stock, worth $204,486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,607Holding current value
$204,486% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
163Shares Held
50.7MCall Options Held
103KPut Options Held
439K-
Janus Henderson Group PLC London, X06.57MShares$203 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$199 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$98 Million0.01% of portfolio
-
Principal Financial Group Inc Des Moines, IA2.88MShares$89.3 Million0.06% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$77.7 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.03B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...